1
|
Tavares-Júnior JWL, Oliveira DN, da Silva JBS, Queiroz Feitosa WL, Sousa AVM, Marinho SC, Cunha LCV, Gaspar SDB, Gomes CMP, de Oliveira LLB, Moreira-Nunes CA, Sobreira EST, de Moraes MEA, Sobreira-Neto MA, Montenegro RC, Braga-Neto P. Post-COVID-19 Cognitive Decline and Apoe Polymorphism: Towards a Possible Link? Brain Sci 2023; 13:1611. [PMID: 38137059 PMCID: PMC10742128 DOI: 10.3390/brainsci13121611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2023] [Revised: 11/17/2023] [Accepted: 11/19/2023] [Indexed: 12/24/2023] Open
Abstract
APOE ε4 polymorphism has been recently described as a possible association with cognitive deficits in COVID-19 patients. This research aimed to establish the correlation between COVID-19 and cognitive impairment, and the APOE gene polymorphism among outpatients. We performed a cross-sectional study with confirmed COVID-19 patients and neurological symptoms that persisted for more than three months from onset. APOE genotypes were determined. The final number of patients included in this study was 219, of which 186 blood samples were collected for APOE genotyping, evaluated 4.5 months after COVID-19. Among the participants, 143 patients (65.3%) reported memory impairment symptoms as their primary concern. However, this complaint was objectively verified through screening tests (Addenbrooke Cognitive Examination-Revised and Mini-Mental State Examination) in only 36 patients (16.4%). The group experiencing cognitive decline exhibited a higher prevalence of the APOE ε4 allele than the normal group (30.8% vs. 16.4%, respectively, p = 0.038). Furthermore, the APOE ε4 allele and anxiety symptoms remained significant after multivariate analysis. This study assessed an outpatient population where cognitive changes were the primary complaint, even in mild cases. Moreover, the ε4 allele, sleep disorders, and anxiety symptoms were more frequent in the cognitive decline group.
Collapse
Affiliation(s)
- José Wagner Leonel Tavares-Júnior
- Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.W.L.T.-J.); (D.N.O.); (W.L.Q.F.); (A.V.M.S.); (L.C.V.C.); (E.S.T.S.); (M.A.S.-N.)
- Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil
| | - Danilo Nunes Oliveira
- Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.W.L.T.-J.); (D.N.O.); (W.L.Q.F.); (A.V.M.S.); (L.C.V.C.); (E.S.T.S.); (M.A.S.-N.)
- Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil
| | - Jean Breno Silveira da Silva
- Medicine Research and Development Center (NPDM), Pharmacogenetics Laboratory, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.B.S.d.S.); (L.L.B.d.O.); (C.A.M.-N.); (M.E.A.d.M.); (R.C.M.)
| | - Werbety Lucas Queiroz Feitosa
- Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.W.L.T.-J.); (D.N.O.); (W.L.Q.F.); (A.V.M.S.); (L.C.V.C.); (E.S.T.S.); (M.A.S.-N.)
- Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil
| | - Artur Victor Menezes Sousa
- Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.W.L.T.-J.); (D.N.O.); (W.L.Q.F.); (A.V.M.S.); (L.C.V.C.); (E.S.T.S.); (M.A.S.-N.)
| | - Samuel Cavalcante Marinho
- Health Sciences Center, State University of Ceará (UECE), Fortaleza 60714-903, CE, Brazil; (S.C.M.); (S.d.B.G.); (C.M.P.G.)
| | - Letícia Chaves Vieira Cunha
- Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.W.L.T.-J.); (D.N.O.); (W.L.Q.F.); (A.V.M.S.); (L.C.V.C.); (E.S.T.S.); (M.A.S.-N.)
- Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil
| | - Safira de Brito Gaspar
- Health Sciences Center, State University of Ceará (UECE), Fortaleza 60714-903, CE, Brazil; (S.C.M.); (S.d.B.G.); (C.M.P.G.)
| | - Carmem Meyve Pereira Gomes
- Health Sciences Center, State University of Ceará (UECE), Fortaleza 60714-903, CE, Brazil; (S.C.M.); (S.d.B.G.); (C.M.P.G.)
| | - Laís Lacerda Brasil de Oliveira
- Medicine Research and Development Center (NPDM), Pharmacogenetics Laboratory, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.B.S.d.S.); (L.L.B.d.O.); (C.A.M.-N.); (M.E.A.d.M.); (R.C.M.)
| | - Caroline Aquino Moreira-Nunes
- Medicine Research and Development Center (NPDM), Pharmacogenetics Laboratory, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.B.S.d.S.); (L.L.B.d.O.); (C.A.M.-N.); (M.E.A.d.M.); (R.C.M.)
| | - Emmanuelle Silva Tavares Sobreira
- Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.W.L.T.-J.); (D.N.O.); (W.L.Q.F.); (A.V.M.S.); (L.C.V.C.); (E.S.T.S.); (M.A.S.-N.)
- Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil
| | - Maria Elisabete Amaral de Moraes
- Medicine Research and Development Center (NPDM), Pharmacogenetics Laboratory, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.B.S.d.S.); (L.L.B.d.O.); (C.A.M.-N.); (M.E.A.d.M.); (R.C.M.)
| | - Manoel Alves Sobreira-Neto
- Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.W.L.T.-J.); (D.N.O.); (W.L.Q.F.); (A.V.M.S.); (L.C.V.C.); (E.S.T.S.); (M.A.S.-N.)
- Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil
| | - Raquel Carvalho Montenegro
- Medicine Research and Development Center (NPDM), Pharmacogenetics Laboratory, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.B.S.d.S.); (L.L.B.d.O.); (C.A.M.-N.); (M.E.A.d.M.); (R.C.M.)
| | - Pedro Braga-Neto
- Neurology Division, Clinical Medicine Department, Faculty of Medicine, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil; (J.W.L.T.-J.); (D.N.O.); (W.L.Q.F.); (A.V.M.S.); (L.C.V.C.); (E.S.T.S.); (M.A.S.-N.)
- Clinical Research Unit, Walter Cantidio University Hospital, Federal University of Ceará (UFC), Fortaleza 60020-181, CE, Brazil
- Health Sciences Center, State University of Ceará (UECE), Fortaleza 60714-903, CE, Brazil; (S.C.M.); (S.d.B.G.); (C.M.P.G.)
| |
Collapse
|